Logo - springer
Slogan - springer

Biomedical Sciences - Neuroscience | Neurotherapeutics

Neurotherapeutics

Neurotherapeutics

The Journal of the American Society for Experimental NeuroTherapeutics

Editor-in-Chief: Maral Mouradian

ISSN: 1933-7213 (print version)
ISSN: 1878-7479 (electronic version)

Journal no. 13311

$99.00 Personal Rate e-only for the Americas
Get Subscription

Online subscription, valid from January through December of current calendar year

Immediate access to this year's issues via SpringerLink

1 Volume(-s) with 4 issue(-s) per annual subscription

Automatic annual renewal

More information: >> FAQs // >> Policy

ASENT PB_Banner_A39778_BBanner_Change_the_World_2017=PB_575x60px
  •  Publishes critical reviews of broad interest on the treatment of neurologic disorders by renowned  experts.
  • Covers emerging treatments for neurologic disorders.
  • Publishes cutting edge original translational research in unmet medical needs for diseases of the nervous system.
  • Explores the molecular underpinnings of neurologic diseases as rationale for targeted therapies.
  • Provides a platform for publishing points-of-view by key opinion leaders on current hot topics.

Neurotherapeutics® is the journal of the American Society for Experimental NeuroTherapeutics (ASENT). Each issue provides critical reviews of an important topic relating to the treatment of neurological disorders, written by international authorities. 

The Journal also publishes original research articles in translational neuroscience including descriptions of cutting edge therapies that cross disciplinary lines and represent important contributions to neurotherapeutics for medical practitioners and other researchers in the field.

Neurotherapeutics ® delivers a multidisciplinary perspective on the frontiers of translational neuroscience, provides perspectives on current research and practice, and covers social and ethical as well as scientific issues.

Future Issue Themes:

January 2017- Pharmacodynamic Markers in Early Diagnosis and Clinical Trial Endpoints in Neurology
Guest Editor: Jeremy Shefner (University of Arizona), Marwan Sabbagh (University of Arizona)

April 2017- Neuro-Oncology: New Concepts and Emerging Therapeutics
Guest Editor: John Laterra (Johns Hopkins University), Burt Nabors (University of Alabama)

July 2017- Emerging Therapies for Neuropsychiatric Disorders
Guest Editor: Jay M. Baraban (Johns Hopkins University), Andrew Pieper (University of Iowa Carver School of Medicine)

October 2017- Current and Future Therapies in Multiple Sclerosis
Guest Editor: Jeffrey Cohen (Cleveland Clinic), Devon Conway (Cleveland Clinic), Le Hanh Hua (Cleveland Clinic )

January 2018- Migraine Therapeutics: Current Practice, Recent Advances and Future Directions 
Guest Editor: Peter Goadsby (King's College), Peter Holland (King's College)

April 2018- The Bidirectional Flow Between the Microbiome and Brain in Neurologic Disease
Guest Editor: Lloyd Kasper (Dartmouth), Javier Ochoa-Reparaz (Eastern Washington University) 

Related subjects » Animal Sciences - Neurology - Neuroscience - Surgery

Impact Factor: 5.166 (2016) * 

Journal Citation Reports®

Abstracted/Indexed in 

Science Citation Index Expanded (SciSearch), Journal Citation Reports/Science Edition, Medline, SCOPUS, EMBASE, Chemical Abstracts Service (CAS), Google Scholar, EBSCO Discovery Service, CSA, Academic OneFile, CSA Environmental Sciences, Current Contents/ Life Sciences, Current Contents/Clinical Medicine, OCLC, SCImago, Summon by ProQuest

For authors and editors


  • Journal Citation Reports®
    2016 Impact Factor
  • 5.166
  • Aims and Scope

    Aims and Scope

    Close

    Neurotherapeutics® is the journal of the American Society for Experimental NeuroTherapeutics (ASENT). Each issue provides critical reviews of an important topic relating to the treatment of neurological disorders, written by international authorities. 

    The Journal also publishes original research articles in translational neuroscience including descriptions of cutting edge therapies that cross disciplinary lines and represent important contributions to neurotherapeutics for medical practitioners and other researchers in the field.

    Neurotherapeutics ® delivers a multidisciplinary perspective on the frontiers of translational neuroscience, provides perspectives on current research and practice, and covers social and ethical as well as scientific issues.

    Future Issue Themes:

    January 2017- Pharmacodynamic Markers in Early Diagnosis and Clinical Trial Endpoints in Neurology
    Guest Editor: Jeremy Shefner (University of Arizona), Marwan Sabbagh (University of Arizona)

    April 2017- Neuro-Oncology: New Concepts and Emerging Therapeutics
    Guest Editor: John Laterra (Johns Hopkins University), Burt Nabors (University of Alabama)

    July 2017- Emerging Therapies for Neuropsychiatric Disorders
    Guest Editor: Jay M. Baraban (Johns Hopkins University), Andrew Pieper (University of Iowa Carver School of Medicine)

    October 2017- Current and Future Therapies in Multiple Sclerosis
    Guest Editor: Jeffrey Cohen (Cleveland Clinic), Devon Conway (Cleveland Clinic), Le Hanh Hua (Cleveland Clinic )

    January 2018- Migraine Therapeutics: Current Practice, Recent Advances and Future Directions 
    Guest Editor: Peter Goadsby (King's College), Peter Holland (King's College)

    April 2018- The Bidirectional Flow Between the Microbiome and Brain in Neurologic Disease
    Guest Editor: Lloyd Kasper (Dartmouth), Javier Ochoa-Reparaz (Eastern Washington University) 

  • Submit Online
  • Open Choice - Your Way to Open Access
  • Instructions for Authors (pdf, 200 kB)
  • Conflict of Interest Form (pdf, 494 kB)

Alerts for this journal

 

Get the table of contents of every new issue published in Neurotherapeutics.